Email updates

Keep up to date with the latest news and content from BMC Psychiatry and BioMed Central.

Open Access Highly Accessed Research article

The PsyCoLaus study: methodology and characteristics of the sample of a population-based survey on psychiatric disorders and their association with genetic and cardiovascular risk factors

Martin Preisig1*, Gérard Waeber2, Peter Vollenweider2, Pascal Bovet2, Stéphane Rothen1, Caroline Vandeleur3, Patrice Guex1, Lefkos Middleton4, Dawn Waterworth5, Vincent Mooser5, Federica Tozzi6 and Pierandrea Muglia6

Author Affiliations

1 Department of Psychiatry, CHUV, Lausanne, Switzerland

2 Department of Medicine, Internal Medicine, CHUV, Lausanne, Switzerland

3 Department of Psychiatry, University Hospital of Geneva, Geneva, Switzerland

4 Division of Neurosciences and Mental Health, Imperial College, London, UK

5 Medical Genetics, GlaxoSmithKline, Philadelphia, Pennsylvania, USA

6 Genetics Division, Drug Discovery, GlaxoSmithKline R&D, Verona, Italy

For all author emails, please log on.

BMC Psychiatry 2009, 9:9  doi:10.1186/1471-244X-9-9

Published: 17 March 2009



The Psychiatric arm of the population-based CoLaus study (PsyCoLaus) is designed to: 1) establish the prevalence of threshold and subthreshold psychiatric syndromes in the 35 to 66 year-old population of the city of Lausanne (Switzerland); 2) test the validity of postulated definitions for subthreshold mood and anxiety syndromes; 3) determine the associations between psychiatric disorders, personality traits and cardiovascular diseases (CVD), 4) identify genetic variants that can modify the risk for psychiatric disorders and determine whether genetic risk factors are shared between psychiatric disorders and CVD. This paper presents the method as well as sociodemographic and somatic characteristics of the sample.


All 35 to 66 year-old persons previously selected for the population-based CoLaus survey on risk factors for CVD were asked to participate in a substudy assessing psychiatric conditions. This investigation included the Diagnostic Interview for Genetic Studies to elicit diagnostic criteria for threshold disorders according to DSM-IV and algorithmically defined subthreshold syndromes. Complementary information was collected on potential risk and protective factors for psychiatric disorders, migraine and on the morbidity of first-degree relatives, whereas the collection of DNA and plasma samples was already part of the original CoLaus survey.


A total of 3,691 individuals completed the psychiatric evaluation (67% participation). The gender distribution of the sample did not differ significantly from that of the general population in the same age range. Although the youngest 5-year band of the cohort was underrepresented and the oldest 5-year band overrepresented, participants of PsyCoLaus and individuals who refused to participate revealed comparable scores on the General Health Questionnaire, a self-rating instrument completed at the somatic exam.


Despite limitations resulting from the relatively low participation in the context of a comprehensive and time-consuming investigation, the PsyCoLaus study should significantly contribute to the current understanding of psychiatric disorders and comorbid somatic conditions by: 1) establishing the clinical relevance of specific psychiatric syndromes below the DSM-IV threshold; 2) determining comorbidity between risk factors for CVD and psychiatric disorders; 3) assessing genetic variants associated with common psychiatric disorders and 4) identifying DNA markers shared between CVD and psychiatric disorders.